SCLX (Scilex Holding Company Common Stock) Stock Analysis - Insider Trades
Scilex Holding Company Common Stock (SCLX) is a publicly traded Healthcare sector company. As of May 21, 2026, SCLX trades at $6.20 with a market cap of $42.06M and a P/E ratio of -0.17. SCLX moved +1.84% today. Year to date, SCLX is -54.68%; over the trailing twelve months it is +20.20%. Its 52-week range spans $3.60 to $39.90. Rallies surfaces SCLX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading SCLX stock inside the company?
Recent SCLX insider activity includes Scilex Holding Co sold 9.66M, Scilex Holding Co sold 7.31M, Scilex Holding Co sold 3.69M, SHAH JAISIM bought 30.00K, and Ji Henry bought 8.89K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
SCLX Key Metrics
Key financial metrics for SCLX
Metric
Value
Price
$6.20
Market Cap
$42.06M
P/E Ratio
-0.17
EPS
$-36.48
Dividend Yield
0.00%
52-Week High
$39.90
52-Week Low
$3.60
Volume
266
Avg Volume
0
Revenue (TTM)
$30.25M
Net Income
$-362.25M
Gross Margin
415.83%
Recent SCLX Insider Trades
Scilex Holding Co sold 9.66M (~$5.21M) on Dec 30, 2025.
Scilex Holding Co sold 7.31M (~$4.79M) on Dec 29, 2025.
Scilex Holding Co sold 3.69M (~$2.77M) on Dec 26, 2025.
SHAH JAISIM bought 30.00K (~$13.80K) on Dec 18, 2024.
SCLX analyst coverage data. Average price target: $0.00.
Common questions about SCLX
Who is trading SCLX stock inside the company?
Recent SCLX insider activity includes Scilex Holding Co sold 9.66M, Scilex Holding Co sold 7.31M, Scilex Holding Co sold 3.69M, SHAH JAISIM bought 30.00K, and Ji Henry bought 8.89K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for SCLX?
Yes. Rallies tracks SCLX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is SCLX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SCLX. It does not provide personalized investment advice.
